Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans
2006; 4: 46
In vivo migration of labeled autologous natural killer cells to liver metastases in patients with colon carcinoma
2006; 4: 49
A gene expression signature associated with survival in metastatic melanoma
2006; 4: 50
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer
2006; 4: 52
Consequences of infertility in developing countries: results of a questionnaire and interview survey in the South of Vietnam
2006; 4: 54
Differential expression profiling between the relative normal and dystrophic muscle tissues from the same LGMD patient
2006; 4: 53
Decreased wheel-running activity in hamsters post myocardial infarction
2006; 4: 51
Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation
2007; 5: 1
Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma
2007; 5: 2
Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid
2006; 4: 55
Therapeutic use of Aldara™ in chronic myeloid leukemia
2007; 5: 4
Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells
2007; 5: 5
Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream
2007; 5: 7
The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization
2007; 5: 6
Cord blood in regenerative medicine: do we need immune suppression?
2007; 5: 8
Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma
2007; 5: 3
CD8 apoptosis may be a predictor of T cell number normalization after immune reconstitution in HIV
2007; 5: 9
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models
2007; 5: 10
Gene expression profiling of cutaneous wound healing
2007; 5: 11
Calcium Sulfate and Platelet-Rich Plasma make a novel osteoinductive biomaterial for bone regeneration
2007; 5: 13
Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine
2007; 5: 16
Tumor-specific T cells signal tumor destruction via the lymphotoxin β receptor
2007; 5: 14
Telomerase immunity from bench to bedside: round one
2007; 5: 12
Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio
2007; 5: 15
CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects
2007; 5: 17
Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70
2007; 5: 18
Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8+ T lymphocytes
2007; 5: 19
Therapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMax®
2007; 5: 20
In support of descriptive studies; relevance to translational research
2007; 5: 21